SK286194B6 - Vodná farmaceutická zmes - Google Patents

Vodná farmaceutická zmes Download PDF

Info

Publication number
SK286194B6
SK286194B6 SK693-2002A SK6932002A SK286194B6 SK 286194 B6 SK286194 B6 SK 286194B6 SK 6932002 A SK6932002 A SK 6932002A SK 286194 B6 SK286194 B6 SK 286194B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
aqueous pharmaceutical
ciclesonide
water
composition according
Prior art date
Application number
SK693-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK6932002A3 (en
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK286194(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of SK6932002A3 publication Critical patent/SK6932002A3/sk
Publication of SK286194B6 publication Critical patent/SK286194B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK693-2002A 1999-10-20 2000-10-20 Vodná farmaceutická zmes SK286194B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20
PCT/JP2000/007351 WO2001028563A1 (en) 1999-10-20 2000-10-20 Ciclesonide-containing aqueous pharmaceutical composition

Publications (2)

Publication Number Publication Date
SK6932002A3 SK6932002A3 (en) 2002-09-10
SK286194B6 true SK286194B6 (sk) 2008-05-06

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
SK693-2002A SK286194B6 (sk) 1999-10-20 2000-10-20 Vodná farmaceutická zmes

Country Status (35)

Country Link
US (2) US8383611B1 (cs)
EP (1) EP1227817B1 (cs)
JP (1) JP4856338B2 (cs)
KR (1) KR100705372B1 (cs)
CN (1) CN1198623C (cs)
AR (1) AR026073A1 (cs)
AT (1) ATE270107T1 (cs)
AU (1) AU776587B2 (cs)
BG (1) BG65799B1 (cs)
BR (1) BRPI0014880B8 (cs)
CA (1) CA2388325C (cs)
CO (1) CO5251406A1 (cs)
CZ (1) CZ297780B6 (cs)
DE (1) DE60011924T2 (cs)
DK (1) DK1227817T3 (cs)
EA (1) EA005201B1 (cs)
ES (1) ES2223595T3 (cs)
HR (1) HRP20020345B1 (cs)
HU (1) HU228894B1 (cs)
IL (2) IL148725A0 (cs)
ME (1) ME00568B (cs)
MX (1) MXPA02003975A (cs)
MY (1) MY121175A (cs)
NO (1) NO327379B1 (cs)
NZ (1) NZ518299A (cs)
PE (1) PE20010713A1 (cs)
PL (1) PL197537B1 (cs)
PT (1) PT1227817E (cs)
RS (1) RS50345B (cs)
SI (1) SI1227817T1 (cs)
SK (1) SK286194B6 (cs)
TR (1) TR200200831T2 (cs)
TW (1) TWI269655B (cs)
WO (1) WO2001028563A1 (cs)
ZA (1) ZA200203078B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
EP3513813A1 (en) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
AU2003273396B2 (en) 2002-08-30 2008-12-11 Covis Pharma B.V. The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2588433A1 (en) * 2004-11-17 2006-05-26 Michael R. Robinson Steroid formulation and methods of treatment using same
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
DK2262506T3 (da) 2008-03-11 2014-06-10 Alcon Res Ltd Meget flokkulerede triamcinolonacetonid-suspensioner med lav viskositet til intravitreal injektion
US11007150B2 (en) 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
IL70489A0 (en) 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
DE3486448T2 (de) 1983-11-14 1997-10-09 Columbia Lab Inc Bioadhäsive Mittel
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
ATE113841T1 (de) 1989-10-31 1994-11-15 Columbia Lab Inc Mittel zur feuchthaltung vaginalen gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
DK0578780T3 (da) 1991-04-03 2003-08-18 Univ Vanderbilt Sænkning af thromboxanniveauer ved perkutan indgivelse af aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
ATE247456T1 (de) 1996-02-27 2003-09-15 Teijin Ltd Puderförmige zusammensetzung zur nasalen anwendung
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
CA2318642A1 (en) 1998-01-22 1999-07-29 Santen Pharmaceutical Co., Ltd. Fluorometholone ophthalmic suspension
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001028517A1 (fr) 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses

Also Published As

Publication number Publication date
SK6932002A3 (en) 2002-09-10
HRP20020345A2 (en) 2005-10-31
BRPI0014880B1 (pt) 2015-08-11
CA2388325A1 (en) 2001-04-26
PT1227817E (pt) 2004-11-30
KR20020060205A (ko) 2002-07-16
SI1227817T1 (en) 2004-12-31
AR026073A1 (es) 2002-12-26
TR200200831T2 (tr) 2002-07-22
MXPA02003975A (es) 2003-09-25
IL148725A0 (en) 2002-09-12
CN1198623C (zh) 2005-04-27
ES2223595T3 (es) 2005-03-01
HK1051003A1 (en) 2003-07-18
MY121175A (en) 2005-12-30
JP4856338B2 (ja) 2012-01-18
BG106517A (en) 2002-12-29
CZ297780B6 (cs) 2007-03-28
ME00568A (en) 2011-12-20
RS50345B (sr) 2009-11-10
TWI269655B (en) 2007-01-01
ME00568B (me) 2011-12-20
BR0014880A (pt) 2002-06-11
PL356190A1 (en) 2004-06-14
CO5251406A1 (es) 2003-02-28
CN1379673A (zh) 2002-11-13
AU776587B2 (en) 2004-09-16
DK1227817T3 (da) 2004-11-15
NO20021866L (no) 2002-04-19
AU7953200A (en) 2001-04-30
ZA200203078B (en) 2003-01-29
NZ518299A (en) 2004-03-26
HRP20020345B1 (en) 2006-12-31
JP2003512330A (ja) 2003-04-02
YU28102A (sh) 2004-12-31
EA200200383A1 (ru) 2002-10-31
IL148725A (en) 2006-12-31
HUP0203756A3 (en) 2004-06-28
US8383611B1 (en) 2013-02-26
PL197537B1 (pl) 2008-04-30
KR100705372B1 (ko) 2007-04-11
NO20021866D0 (no) 2002-04-19
EP1227817A1 (en) 2002-08-07
ATE270107T1 (de) 2004-07-15
EA005201B1 (ru) 2004-12-30
CA2388325C (en) 2007-09-18
CZ20021284A3 (cs) 2002-07-17
DE60011924T2 (de) 2005-07-07
PE20010713A1 (es) 2001-07-13
WO2001028563A1 (en) 2001-04-26
HU228894B1 (hu) 2013-06-28
US20130095146A1 (en) 2013-04-18
BRPI0014880B8 (pt) 2021-05-25
NO327379B1 (no) 2009-06-22
BG65799B1 (bg) 2009-12-31
DE60011924D1 (de) 2004-08-05
EP1227817B1 (en) 2004-06-30
HUP0203756A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
US20130095146A1 (en) Ciclesonide containing aqueous pharmaceutical composition
CA2272586C (en) Rapidly disintegrable pharmaceutical composition
EP2089060B1 (en) Liquid preparation comprising a complex of pimobendan and cyclodextrin
US8530507B2 (en) Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs
BR112019014712A2 (pt) Tratamento médio que compreende a administração entérica de edaravona
EP2813215A1 (en) 2,2',6,6'-tetraisopropyl-4,4'-2-biphenol lipid microsphere preparation and preparation method therefor
KR20010089887A (ko) 수성의약품 조성물
US6818662B2 (en) Pharmaceutical composition
US20220031642A1 (en) Niclosamide Formulations and Methods of Use
CN101511362A (zh) 包含抗肿瘤剂的含水制剂
KR20150096787A (ko) Ｎ-[5-[2-(3,5-디메톡시페닐)에틸]-2ｈ-피라졸-3-일]-4-[(3ｒ,5ｓ)-3,5-디메틸피페라진-1-일]벤즈아미드의 약학 제제
JP2025527261A (ja) 新規製剤
WO2014007239A1 (ja) アムホテリシンｂ含有組成物
CN1832749A (zh) 粘性稳定的含铋药物组合物
SAJJA FORMULATION AND IN-VITRO EVALUATION OF ORALLY ADMINISTERED GASTRO-RETENTIVE FLOATING TABLETS OF IMATINIB

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: TAKEDA GMBH, KONSTANZ, DE

Effective date: 20130725

PC4A Assignment and transfer of rights

Owner name: NYCOMED ASSET MANAGEMENT GMBH, KONSTANZ, DE

Free format text: FORMER OWNER: TAKEDA GMBH, KONSTANZ, DE

Effective date: 20151210

Owner name: NYCOMED GERMANY HOLDING GMBH, KONSTANZ, DE

Free format text: FORMER OWNER: NYCOMED ASSET MANAGEMENT GMBH, KONSTANZ, DE

Effective date: 20151210

TC4A Change of owner's name

Owner name: TAKEDA GMBH, KONSTANZ, DE

Effective date: 20151210

PC4A Assignment and transfer of rights

Owner name: ASTRAZENECA AB, SE SOEDERTAELJE, SE

Free format text: FORMER OWNER: TAKEDA GMBH, KONSTANZ, DE

Effective date: 20161028

PC4A Assignment and transfer of rights

Owner name: COVIS PHARMA B.V., ZUG, CH

Free format text: FORMER OWNER: ASTRAZENECA AB, SOEDERTAELJE, SE

Effective date: 20190814

MK4A Patent expired

Expiry date: 20201020